DuoGenic StemCells Corp. (7607)
Market Closed
16 Oct, 05:30 AM
TWSE 
NT$
8. 25
-0.05
-0.6024%
NT$
- Market Cap
- P/E Ratio
124% Div Yield
13,353 Volume
- Eps
NT$ 8.3
Previous Close Want to track 7607 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DuoGenic StemCells Corp. (7607) Statistics
Valuation metrics
Market Cap -
Enterprise value 302.92M
Trailing P/E (ttm) -8.26
Forward P/E -
PEG ratio -0.6
Price/Sales (ttm) 15
Price/Book (mrq) 7.22
Enterprise Value/Revenue 14.71
Enterprise Value/EBITDA -10.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 40.79K
Average volume (90 days) 17.93K
Price summary
52-Week low 8.03
52-Week high 21.5
Beta -
50-Day moving average 10.47
200-Day moving average 13.07
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 28 Aug 2026
Ex-Dividend Date 28 Aug 2026
Last split factor 11:10
Last split Date 28 Aug 2007
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.67%
Operating margin -1.67%
Operational effectiveness
Return on assets -0.45%
Return on equity -0.74%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.58
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.96
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.92
Total debt (mrq) -
Total Debt/Equity (mrq) 0.64
Current ratio (mrq) 1.86%
Book value per share (mrq) 1.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
